Use cautionDrug recall · FDA · Published July 13, 2023
Sun Pharmaceutical Methylphenidate Tablets Recall: Metal in Tablets
Sun Pharmaceutical recalls 20mg methylphenidate tablets with metal embedded in some tablets. This could cause injury if swallowed. Consumers should contact the company for details.
“Sun Pharmaceutical Methylphenidate Tablets Recall: Metal in Tablets.” GovInfoNow, updated August 17, 2026. https://govinfonow.com/recall/33374-sun-pharmaceutical-methylphenidate-tablets-recall-metal-in-tablets. Based on FDA recall #D-0940-2023 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0940-2023%22&limit=1).
The FDA announced on July 13, 2023, that Sun Pharmaceutical Industries Inc. is recalling Methylphenidate Hydrochloride Tablets, USP 20mg due to the presence of a metal foreign substance embedded in the tablets. This voluntary Class II recall affects 7,313 bottles distributed nationwide.
Manufacturer: Ohm Laboratories Inc., New Brunswick, NJ 08901
Distributor: Sun Pharmaceutical Industries Inc., Cranbury, NJ 08512
NDC: 57664-230-88
Lot Code: AC74459
Expiration Date: 07/31/2024
Quantity: 7,313 bottles
The hazard
The recall involves the presence of a foreign substance, specifically metal embedded in a tablet. The FDA classified this as a Class II recall.
Context
GovInfoNow's records show Sun Pharmaceutical Industries Inc. has 93 other recalls on record since May 21, 2013. Other recent recalls of similar products include Sun Pharmaceutical Nystatin Cream Recall (Sept. 14, 2026), Sun Pharmaceutical Carbamazepine Tablets Recall (Aug. 3, 2026), and Sun Pharmaceutical Perampanel 6mg Tablets Recall (June 17, 2026). Other recent recalls of similar products include Guardian Drug Family Wellness Antacid Tablets Recall (May 28, 2026), Guardian Market Basket Antacid Recall (May 28, 2026), and Guardian Drug TopCare Antacid Tablets Recall (May 28, 2026).
How to tell if you have this one
Check for the product name 'Methylphenidate Hydrochloride Tablets, USP 20mg', NDC 57664-230-88, lot AC74459, manufactured by Ohm Laboratories. The product was distributed by Sun Pharmaceutical in the US.
Brand
Sun Pharmaceutical
Category
Drug
Based on the official FDA remedy
What to do — step by step
Check Product Details
Look for the NDC code 57664-230-88 and lot number AC74459 on the packaging.
Contact Sun Pharmaceutical
Reach out to Sun Pharmaceutical for instructions on what to do with the product.
Where it went and when
Where it was distributed
Distributed nationwide.
Nationwide
Not listed
FDA distribution: “Nationwide” States read from FDA’s own wording; “not listed” means the notice does not name it.
Distributed nationwide.
Recall timeline
FDA terminated this recall 7 months after the firm started it.
1Firm started the recall
2FDA classified it Class II
3Published in FDA’s Enforcement Report
4FDA terminated the recall
Dates from the agency record only; steps without a date are left out.
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
Official source: FDA Recall #D-0940-2023 (July 13, 2023) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0940-2023 to see it in context.
Plain-language summary written by qwen3:4b on August 17, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.